Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Study shows CRC risk higher in people with insulin-requiring type 2 diabetes


A study published today in the American Gastroenterological Association’s journal Gastroenterology concludes that patients with type 2 diabetes mellitus who require long-term insulin therapy are at a significantly increased risk for colorectal cancer.

Results of this retrospective cohort study, conducted on 24,918 people with type 2 diabetes, suggest that those who received more than three years of insulin therapy during the follow-up period of the study have more than three times the risk of developing colorectal cancer than those who did not receive insulin therapy.

The prevalence of type 2 diabetes is at epidemic proportions and many patients will eventually require insulin therapy to manage their disease. "It is yet to be determined whether the increased risk of colorectal cancer is due to a growth promotional effect of exogenous insulin, the severity of type 2 diabetes mellitus, or both," said Dr. Yu-Xiao Yang, lead study author. "However, we are hopeful that the identification of this group of patients at a significantly higher risk of developing colorectal cancer will lead to more effective cancer prevention efforts."

Patients should not discontinue insulin therapy as a result of this study, but should ask their doctors about the highly effective colorectal cancer screening methods currently available. If confirmed in additional studies, practicing physicians should consider long-term insulin therapy as a marker of elevated colorectal cancer risk.

Further studies are needed to determine whether a more stringent colorectal cancer screening program is needed in this population. "At this point, we advocate for strict adherence to the existing colorectal cancer screening guidelines in this patient population, as these measures can effectively reduce the risk of developing colorectal cancer," added Yang.

Colorectal cancer is the second leading cause of cancer-related death in the United States. Type 2 diabetes is a condition where the body responds poorly to the insulin that it produces, and has to make an excessive amount of insulin to overcome the poor response in order to maintain blood sugar control. At advanced stages, the body produces less and less insulin, until eventually insulin treatment is needed. Approximately 18 million Americans have diabetes--90 to 95 percent of these cases are type 2 diabetes.

Previous studies have suggested that type 2 diabetes mellitus may be independently associated with increased colorectal cancer risk. Excess internal insulin production in type 2 diabetes has been proposed as the main potential reason. However, the effect of externally administered insulin on cancer risk has not been studied in humans.

The American Gastroenterological Association (AGA) and multiple government agencies and professional societies underscore the importance of colorectal cancer screening for all individuals 50 years of age and older. Currently, there are a number of approved tests that may be used to screen for colorectal cancer, including barium enema, fecal occult blood test, flexible sigmoidoscopy and colonoscopy.

About the Study

Lead study author Dr. Yu-Xiao Yang is an instructor of medicine in the University of Pennsylvania School of Medicine’s division of gastroenterology. Researchers conducted a retrospective cohort study among all patients with a diagnosis of type 2 diabetes in the General Practice Research Database, a collection of primary outpatient medical records for hundreds of general practitioner practices in the United Kingdom. Patient information in the database includes demographic information, prescription drugs, diagnoses, hospital admissions and deaths. Of the 24,918 patients with type 2 diabetes, 3,160 required insulin. Results of the study are generalized and can be applied to various national populations.

Kimberly Wise | EurekAlert!
Further information:

More articles from Studies and Analyses:

nachricht Diagnoses: When Are Several Opinions Better Than One?
19.07.2016 | Max-Planck-Institut für Bildungsforschung

nachricht High in calories and low in nutrients when adolescents share pictures of food online
07.04.2016 | University of Gothenburg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>